<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2016, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 13 Apr 2016 12:10:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  8-K        Biota Pharmaceuticals,    For: Apr 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Apr+11/11498775.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Apr+11/11498775.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Apr+11/11498775.html</guid>
   <pubDate>Wed, 13 Apr 2016 12:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'</title>
   <link>http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:06:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'</title>
   <link>http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:06:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'</title>
   <link>http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:06:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'</title>
   <link>http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:06:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'</title>
   <link>http://www.streetinsider.com/Hot+Corp.+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Corp.+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:06:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'</title>
   <link>http://www.streetinsider.com/Hot+Corp.+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Corp.+News/Biota+Pharma+%28BOTA%29+Becomes+Aviragen+Therapeutics%3B+Will+Trade+Under+%27AVIR%27/11492830.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:06:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharmaceuticals, Inc. Announces Name Change to Aviragen Therapeutics, Inc. (NASDAQ: AVIR)</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharmaceuticals, Inc. Announces Name Change to Aviragen Therapeutics, Inc. (NASDAQ: AVIR)</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharmaceuticals, Inc. Announces Name Change to Aviragen Therapeutics, Inc. (NASDAQ: AVIR)</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals%2C+Inc.+Announces+Name+Change+to+Aviragen+Therapeutics%2C+Inc.+%28NASDAQ%3A+AVIR%29/11492764.html</guid>
   <pubDate>Tue, 12 Apr 2016 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVIR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Form  8-K        Biota Pharmaceuticals,    For: Apr 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Apr+11/11491117.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Apr+11/11491117.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Apr+11/11491117.html</guid>
   <pubDate>Mon, 11 Apr 2016 15:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Commences BTA585 Phase 2a in RSV Infections</title>
   <link>http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html</guid>
   <pubDate>Mon, 11 Apr 2016 07:03:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Commences BTA585 Phase 2a in RSV Infections</title>
   <link>http://www.streetinsider.com/FDA/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html</guid>
   <pubDate>Mon, 11 Apr 2016 07:03:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharma (BOTA) Commences BTA585 Phase 2a in RSV Infections</title>
   <link>http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Biota+Pharma+%28BOTA%29+Commences+BTA585+Phase+2a+in+RSV+Infections/11489335.html</guid>
   <pubDate>Mon, 11 Apr 2016 07:03:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Initiates Phase 2a Efficacy Study of BTA585 for the Treatment of RSV Infections</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Initiates+Phase+2a+Efficacy+Study+of+BTA585+for+the+Treatment+of+RSV+Infections/11489301.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Initiates+Phase+2a+Efficacy+Study+of+BTA585+for+the+Treatment+of+RSV+Infections/11489301.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Initiates+Phase+2a+Efficacy+Study+of+BTA585+for+the+Treatment+of+RSV+Infections/11489301.html</guid>
   <pubDate>Mon, 11 Apr 2016 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Initiates Phase 2a Efficacy Study of BTA585 for the Treatment of RSV Infections</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Initiates+Phase+2a+Efficacy+Study+of+BTA585+for+the+Treatment+of+RSV+Infections/11489301.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Initiates+Phase+2a+Efficacy+Study+of+BTA585+for+the+Treatment+of+RSV+Infections/11489301.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Initiates+Phase+2a+Efficacy+Study+of+BTA585+for+the+Treatment+of+RSV+Infections/11489301.html</guid>
   <pubDate>Mon, 11 Apr 2016 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharmaceuticals to Present at 15th Annual Needham Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals+to+Present+at+15th+Annual+Needham+Healthcare+Conference/11480220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals+to+Present+at+15th+Annual+Needham+Healthcare+Conference/11480220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals+to+Present+at+15th+Annual+Needham+Healthcare+Conference/11480220.html</guid>
   <pubDate>Wed, 06 Apr 2016 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Form  8-K        Biota Pharmaceuticals,    For: Mar 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Mar+23/11447924.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Mar+23/11447924.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Biota+Pharmaceuticals%2C++++For%3A+Mar+23/11447924.html</guid>
   <pubDate>Thu, 24 Mar 2016 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Spero Therapeutics Acquires Biota Pharma's (BOTA) Antibiotic Assets</title>
   <link>http://www.streetinsider.com/Spinoffs/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Spinoffs/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Spinoffs/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html</guid>
   <pubDate>Thu, 17 Mar 2016 06:34:38 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Spero Therapeutics Acquires Biota Pharma's (BOTA) Antibiotic Assets</title>
   <link>http://www.streetinsider.com/Corporate+News/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html</guid>
   <pubDate>Thu, 17 Mar 2016 06:34:38 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Spero Therapeutics Acquires Biota Pharma's (BOTA) Antibiotic Assets</title>
   <link>http://www.streetinsider.com/Management+Comments/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Spero+Therapeutics+Acquires+Biota+Pharma%27s+%28BOTA%29+Antibiotic+Assets/11428081.html</guid>
   <pubDate>Thu, 17 Mar 2016 06:34:38 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
  <item>
   <title>Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals+Announces+Sale+of+Antibiotic+Assets+to+Spero+Therapeutics/11428070.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals+Announces+Sale+of+Antibiotic+Assets+to+Spero+Therapeutics/11428070.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Biota+Pharmaceuticals+Announces+Sale+of+Antibiotic+Assets+to+Spero+Therapeutics/11428070.html</guid>
   <pubDate>Thu, 17 Mar 2016 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BOTA</category>
   	  </item>
 </channel>
</rss>
